Catheter-directed thrombectomy with the JETi8 in the treatment of acute superior vena cava syndrome.
J Vasc Surg Cases Innov Tech
; 8(3): 545-548, 2022 Sep.
Article
in English
| MEDLINE | ID: covidwho-2041998
ABSTRACT
Superior vena cava syndrome can lead to significant morbidity and mortality, particularly in acute settings. We report a case of an acute Port-a-Cath-associated thrombosis of the superior vena cava. Percutaneous catheter-directed thrombectomy was performed using the JETi8 thrombectomy device with additional angioplasty and stenting, allowing rapid flow restoration and rapid clinical recovery. Postoperative anticoagulation was initiated and pursued lifelong. This report is unique in illustrating how JETi8 thrombectomy seems to be a safe and effective therapy, allowing rapid flow restoration, rapid clinical improvement, and persistent patency at 6 months.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
J Vasc Surg Cases Innov Tech
Year:
2022
Document Type:
Article
Affiliation country:
J.jvscit.2022.07.009
Similar
MEDLINE
...
LILACS
LIS